20.01.2015 Views

View - ResearchGate

View - ResearchGate

View - ResearchGate

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

170 Pattenden and Thomas<br />

1. Introduction<br />

Affinity chromatography of maltose-binding protein (MBP) (1) exploits the<br />

binding of amylose that is functionalized as the stationary phase to magnetic<br />

beads, agarose or an inert matrix. As for other forms of affinity chromatography,<br />

the successful purification using amylose affinity chromatography is critically<br />

linked to an intimate understanding of the biomolecular interactions (and<br />

complications) that can occur due to the specific and unique features of MBP<br />

and amylose biology. Likewise a limitation to broader applications, greater<br />

developments and the reason for misunderstandings that arise with regard to<br />

MBP and amylose affinity chromatography are the failures to completely grasp<br />

and exploit aspects of this biology. This chapter highlights the facets of MBP<br />

and amylose biology and chemistry that are relevant to affinity purification and<br />

discusses how these facets negatively impact purification or can be exploited<br />

to achieve purification. Methods are presented for native purification in batch,<br />

semi-batch and fast protein liquid chromatography (FPLC) modes, and a new<br />

matrix-assisted dialysis refolding method is described that is suitable for batch<br />

and semi-batch modes.<br />

MBP, also referred to as maltodextrin-binding protein (and sometimes<br />

written unhyphenated), can be expressed at arguably the highest levels for<br />

any recombinant carrier protein. Developed by New England BioLabs from<br />

Escherichia coli, there are now six constructs commercially available for<br />

periplasmic or cytoplasmic expression with a Factor Xa, Genenase I or<br />

Enterokinase protease site engineered into the constructs (2). There is also<br />

a series of MBP constructs developed by David S Waugh (National Cancer<br />

Institute at Frederick) that can be obtained from the non-profit distributor of<br />

biological reagents AddGene (3,4,5) which include Gateway© His6-MBP and<br />

non-E. coli-sourced MBP, typically using a TEV protease site (tobacco etch<br />

virus nuclear inclusion protease site) (4,5). New England BioLabs also provide<br />

a range of suitable E. coli host cells that are useful for MBP expression free<br />

of charge and have very reasonable licensing and royalty terms, making MBPbased<br />

recombinant carrier protein expression and purification also one of the<br />

most economically achievable affinity chromatography systems available for<br />

both research and commercial ventures.<br />

MBP belongs to the bacterial superfamily of periplasmic-binding proteins<br />

that are monomeric bilobular proteins with molecular weights in the range<br />

of 25–45 kDa, containing a single ligand-binding site with micromolar dissociation<br />

constants for diverse ligands ranging from ions (6–9), amino acids<br />

(10–13), oligopeptides (14,15) and carbohydrates (16,17) (see Note 1 for MBP<br />

biophysical properties). Within Gram negative bacteria, the periplasmic-binding<br />

proteins are involved in the chemotaxis and transport of their respective ligands.<br />

Unlike Gram positive bacterium that directly sense and responds to specific

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!